Offstream
news

---

Changes

1. The U.S. CDC approves the Pfizer–BioNTech COVID-19 vaccine for children aged 5 and 11.
   2021-11-05 01:06:16 (First version)
2. The U.S. CDC approves the Pfizer–BioNTech COVID-19 vaccine for children aged 5 and 11 years old.
   (Current version)

---

Related

Pfizer and BioNTech begin a clinical trial testing of their COVID-19 vaccine on healthy children between the ages of six months and 11 years, which is considered a crucial step towards vaccinating children.
2021-03-25

U.S. President Joe Biden announces that his administration has finalized a deal purchasing a total of 200 million vaccine doses from Moderna and Pfizer.
2021-02-11

The government signs a deal with Pfizer and BioNTech to buy an additional 12.2 million doses of the tozinameran vaccine.
2021-01-11

Vaccine developer Pfizer announces that lab studies have concluded that the joint Pfizer–BioNTech vaccine remains effective against mutation variants of the SARS-CoV-2 virus, including Variant of Concern 202012-01 and the 501.V2 variant.
2021-01-8

Contrary to the strategy adopted by the United Kingdom, Spain is expected to maintain its plan to administer two doses per person of the COVID-19 vaccine tozinameran, which is the recommendation of the manufacturer Pfizer-BioNTech. Germany is also considering the single-dose strategy.
2021-01-4

Israeli Prime Minister Benjamin Netanyahu became the first person in Israel to receive the vaccine made by Pfizer and BioNTech and getting the shot on live television.
2020-12-19

Bahrain grants emergency use authorization for the COVID-19 vaccine made by Pfizer and BioNTech, becoming the second country after the United Kingdom to approve the vaccine.
2020-12-4

The United Kingdom approves the BNT162b2 vaccine made by Pfizer and BioNTech for widespread use, becoming the first country in the world to approve the vaccine. The government states that the vaccine will be rolled out early next week.
2020-12-2

The Health Ministry announces that Spain will receive 20 million vaccine doses from Pfizer and BioNTech by early 2021.
2020-11-10

The government announces that they have signed a deal with Pfizer and BioNTech to purchase 1.5 million vaccine doses for 750,000 people in the country.
2020-10-11